| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 07/16/2009 | US20090181986 Substituted heterocyclic compounds |
| 07/16/2009 | US20090181985 IMIDAZO[1,2-b]PYRIDAZINE COMPOUND |
| 07/16/2009 | US20090181982 Substituted pyrroline kinase inhibitors |
| 07/16/2009 | US20090181976 Use of Compounds Binding to the Sigma Receptor for the Treatment of Metabolic Syndrome |
| 07/16/2009 | US20090181972 Novel Inhibitors of Cysteine Proteases, the Pharmaceutical Compositions Thereof and their Therapeutic Applications |
| 07/16/2009 | US20090181967 New compounds I |
| 07/16/2009 | US20090181949 1h-imidazole derivative having cb1, agonistic, cb1 partial agonistic or cb1 antagnistic activity |
| 07/16/2009 | US20090181943 Inhibitors of Histone Deacetylase |
| 07/16/2009 | US20090181939 Azetidinecarboxamide Derivatives And Their Use In The Treatment Of CB1 Receptor Mediated Disorders |
| 07/16/2009 | US20090181929 Organic compounds |
| 07/16/2009 | US20090181928 Organic compounds |
| 07/16/2009 | US20090181925 Compositions for treating and preventing hyperlipidemia |
| 07/16/2009 | US20090181917 Men1 gene for diagnosis and treatment of diabetes |
| 07/16/2009 | US20090181912 GLP/1/EXENDIN 4 IgG Fc FUSION CONSTRUCTS FOR TREATMENT OF DIABETES |
| 07/16/2009 | US20090181910 Method of prevention and alleviation of toxicity by modulation of irf3 |
| 07/16/2009 | US20090181905 Crystalline form of 1' -(1-methylethyl)-4' -[(2-fluoro-4-methoxyphenyl)methyl]-5' -methyl-1h-pyrazol-3' -o-beta-d-glucopyranoside, a method for its preparation and the use thereof for preparing medicaments |
| 07/16/2009 | US20090181904 Method for regulating nutrient absorption with ginsenosides |
| 07/16/2009 | US20090181886 Method for Determining the Concentration of the Adipocytic Form of the Fatty Acid Binding Protein (A-FABP, FABP4, P2) |
| 07/16/2009 | US20090181885 Novel compounds and their effects on feeding behaviour |
| 07/16/2009 | US20090181884 Novel apolipoprotein gene involved in lipid metabolism |
| 07/16/2009 | US20090181883 HUMAN CHORIONIC GONADOTROPIN (hCG) FORMULATIONS FOR FACILITATING WEIGHT LOSS AND BODY CONTOURING |
| 07/16/2009 | US20090181437 Method for producing a conjugated linoleic acid glyceride |
| 07/16/2009 | US20090181109 Nanoveson™: treatment, biomarkers and diagnostic tests for liver diseases and comorbid diseases |
| 07/16/2009 | US20090181095 Oxidative stress inhibitor |
| 07/16/2009 | US20090181085 Use of certain dialkyl fumarates for the preparation of pharmaceutical preparations for use in transplantation medicine or for the therapy of autoimmune diseases and said compositions in the form of micro-tablets or pellets; dimethyl fumarate |
| 07/16/2009 | US20090181081 Systemic Treatment of Pathological Conditions Resulting From Oxidative Stress and/or Redox Imbalance |
| 07/16/2009 | US20090181079 Methods of making and using theaflavin, theaflavin-3-gallate, theaflavin-3'-gallate and theaflavin 3,3'-digallate and mixtures thereof |
| 07/16/2009 | US20090181076 Drug Release From Nanoparticle-Coated Capsules |
| 07/16/2009 | US20090181058 Injectable solid hyaluronic acid carriers for delivery of osteogenic proteins |
| 07/16/2009 | US20090181037 Semi-Synthetic GLP-1 Peptide-FC Fusion Constructs, Methods and Uses |
| 07/16/2009 | CA2711862A1 Composition for improving nutritional status of the elderly, reducing frequency of fever of the elderley and/or increasing immunocompetence of the elderly |
| 07/16/2009 | CA2711834A1 Synthetic triterpenoids and methods of use in the treatment of disease |
| 07/16/2009 | CA2711814A1 Capsule formulation |
| 07/16/2009 | CA2711809A1 Compositions and methods for increasing muscle mass, strength, and functional performance in the elderly |
| 07/16/2009 | CA2711652A1 Chemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomalies |
| 07/16/2009 | CA2711611A1 Composition for reducing oxidative stress and/or side effects occurring during cancer chemotherapy or improving nutritional status during cancer chemotherapy |
| 07/16/2009 | CA2711288A1 Lactam inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 07/16/2009 | CA2702012A1 5,6-diaryl pyridines substituted in the 2- and 3-position, preparation thereof and therapeutic use thereof |
| 07/15/2009 | EP2078719A1 Compound having bicyclic pyrimidine structure and pharmaceutical composition comprising the compound |
| 07/15/2009 | EP2078523A1 Agent for suppression of gastric emptying comprising 4-hydroxyisoleucine |
| 07/15/2009 | EP2078031A2 Monoesters of estrogens with conjugated linoleic acid and uses thereof |
| 07/15/2009 | EP2078021A2 Pyrazolopyrimidine analogs and their use as mtor kinase and pi3 kinase inhibitors |
| 07/15/2009 | EP2078001A1 Diazepane-acetamide derivatives as selective 11 -hsd1 inhibitors |
| 07/15/2009 | EP2078000A1 Benzoyl amino heterocyclyl compounds as glucokinase (glk) activators |
| 07/15/2009 | EP2077902A2 Use of nutritional compositions for preventing disorders |
| 07/15/2009 | EP2077855A1 Therapeutic use of gba2 |
| 07/15/2009 | EP2077851A1 A pharmaceutical composition comprising cordycepin for the treatment and prevention of obesity |
| 07/15/2009 | EP2077846A2 Benzoxazepine compounds, their preparation and use |
| 07/15/2009 | EP2077830A1 Methods, compositions, and formulations for the treatment of thyroid eye disease |
| 07/15/2009 | EP2077728A2 Use of nutritional compositions for preventing disorders |
| 07/15/2009 | EP1874304B1 Benzotriazole derivatives as cannabinoid receptor antagonists |
| 07/15/2009 | EP1675625A4 Mechanism-based targeted pancreatic beta cell imaging and therapy |
| 07/15/2009 | EP1624871B1 Method of treating atherosclerosis, dyslipidemias and related conditions and pharmaceutical compositions |
| 07/15/2009 | EP1389118B1 Single-daily-dose antidiabetic oral pharmaceutical form comprising a biguanide and at least another active principle |
| 07/15/2009 | EP1268802B1 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 07/15/2009 | EP1141015B1 Insulin-like growth factor (igf) i mutant variants |
| 07/15/2009 | EP1075272B1 Methods for treating diabetes by inhibiting gdf-8 |
| 07/15/2009 | EP1063971B1 Controlled release oral tablet having a unitary core |
| 07/15/2009 | CN101481405A Somatostatin-dopamine chimeric analogs |
| 07/15/2009 | CN100513570C Regulation effect of conjugated frame transport protein ABC1 |
| 07/15/2009 | CN100513406C Novel quinuclidine derivatives and their use |
| 07/15/2009 | CN100513404C Novel compunds, pharmaceutical compositions containing same, and methods of use for same |
| 07/15/2009 | CN100512812C Method of extracting red indigo peucin and red indigo peucin cinnamic ester from Korean Angelica |
| 07/15/2009 | CN100512811C Hepatoprotective activity of 10-o-p-hydroxybenzoyiaucubin |
| 07/15/2009 | CN100512809C Compounds and methods of treating transplant rejection |
| 07/14/2009 | US7560586 Acid and ester compounds and methods of using the same |
| 07/14/2009 | US7560569 (2S,4S)-1-[[(4-carbamoylbicyclo[2.2.2]oct-1-yl)amino]acetyl]-4-fluoropyrrolidine-2-carbonitrile, for treating type II diabetes; increase glucagon-like peptide activity |
| 07/14/2009 | US7560558 quinoline pyridyl derivatives antagonist; antitumor agents; renal disease, hepatic fibrosis, cirrhosis, fibroid lung, scleroderma, wound healing, arthritis, congestive cardiac disease, ulcer, ocular disorder, cornea disorder, diabetic nephropathy |
| 07/14/2009 | US7560552 Thiopyrimidine and isothiazolopyrimidine kinase inhibitors |
| 07/14/2009 | US7560548 antiinflammatory agent N-{[(2S)-4-(3,4-dichlorobenzyl)morpholin-2-yl]methyl}cyclopropane carboxamide; bronchitis, asthma, chronic obstructive pulmonary disease and rhinitis |
| 07/14/2009 | US7560546 Tyrosine kinase inhibitors |
| 07/14/2009 | US7560486 An isotonic lipid emulsion free of vegetable oils:(i) 78 to 95% by weight of medium chain triglycerides (MCT), (ii) 5 to 22% by weight of fish oil; to increase the amount of omega-3 fatty acids of cell membranes of organs and tissues |
| 07/14/2009 | US7560480 Alkyl-containing 5-acylindolinones, the preparation thereof and their use as medicaments |
| 07/14/2009 | US7560479 3,6-Disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists |
| 07/14/2009 | US7560475 3-(2-{5-methyl-2-[4-(trifluoromethyl)piperidin-1-yl]-1,3-thiazol-4-yl}ethoxy)phenyl]acetic acid,peroxime proliferator-activated receptor antagonists; side effect reduction; very low toxicity, especially hepatotoxicity; metabolic disorders; antidiabetic agents; anticholesterol agents; antilipemic agents |
| 07/14/2009 | US7560474 Derivatives of pyridilethanol (phenylethyl) amines as inhibitors of cholesterol biosynthesis, process for their preparation and pharmaceutical compositions containing them |
| 07/14/2009 | US7560473 Amine derivative with potassium channel regulatory function, its preparation and use |
| 07/14/2009 | US7560463 Diaryl ethers as opioid receptor antagonists |
| 07/14/2009 | US7560460 2-[(4-Chlorophenyl)methyl]-1-(4- {2-[(cyclopropylmethyl)-(methylsulfonyl)amino]phenyl }-piperazinyl) -4-(2-(1,2,3,4-tetrahydroisoquinolyl))butane-1,4-dione; obesity/dietietics; melanocortin receptor angonists; prophylaxis/treatment of diseases involving activation of the melanocortin recepetors (MCR) |
| 07/14/2009 | US7560458 Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors |
| 07/14/2009 | US7560455 3-Amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 07/14/2009 | US7560450 Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions |
| 07/14/2009 | US7560443 Mixtures of fructose, sucrose and lactose as a low-calorie bulk sweetener with reduced glycemic index |
| 07/14/2009 | US7560442 For prophylaxis and therapy of diabetes mellitus Type I and Type II, inflammation, cancer, necrosis, gastric ulcers, neurodegenerative diseases (Alzheimer's disease, Parkinson's disease), neuropathic diseases, neuropathic pain and polyneuropathy |
| 07/14/2009 | US7560441 Modified and stabilized GDF propeptides and uses thereof |
| 07/14/2009 | US7560425 Pharmaceutical composition consisting of rapamycine and gastrin 17(LEU15) and a method for treating diabetes |
| 07/14/2009 | US7560132 Oilseed processing |
| 07/14/2009 | CA2386790C Chromium-histidine complexes as nutrient supplements |
| 07/14/2009 | CA2379841C Biphenyl derivatives, the preparation thereof and their use as medicaments |
| 07/14/2009 | CA2338090C Nutritional and therapeutic compositions of 3-hydroxyacids for increasing blood ketone bodies |
| 07/14/2009 | CA2331410C Methods for treating diabetes by inhibiting gdf-8 |
| 07/14/2009 | CA2262972C Compositions of plant carbohydrates as dietary supplements |
| 07/11/2009 | CA2639285A1 Solid dosage formulations containing weight-loss drugs |
| 07/09/2009 | WO2009086440A1 2-methylene-20-methyl-19,24,25,26,27-pentanor-vitamin d analogs |
| 07/09/2009 | WO2009086439A2 2-methylene-(20s,25s)-19,26-dinor-vitamin d analogs |
| 07/09/2009 | WO2009086436A1 (20s)-23,23-difluoro-2-methylene-19-nor-bishomopregnacalciferol-vitamin d analogs |
| 07/09/2009 | WO2009086138A1 Benzimidazole compounds |
| 07/09/2009 | WO2009086130A1 Imidazo [1,2-b] pyridazine compounds as modulators of liver x receptors |
| 07/09/2009 | WO2009086129A1 Pyrazolo [1,5-a] pyrimidine compounds |
| 07/09/2009 | WO2009086123A1 Imidazo [1,2-a] pyridine compounds |